Literature DB >> 25236500

HLA class II peptide tetramers vs allergen-induced proliferation for identification of allergen-specific CD4 T cells.

D Van Hemelen1, V Mahler, G Fischer, I Fae, V Reichl-Leb, W Pickl, M Jutel, S Smolinska, C Ebner, B Bohle, B Jahn-Schmid.   

Abstract

BACKGROUND: Fluorescence-labeled MHC class II/peptide tetramer complexes are considered as optimal tools to characterize allergen-specific CD4(+) T cells, but this technique is restricted to frequently expressed HLA class II molecules and knowledge of immunodominant epitopes. In contrast, allergen-stimulated proliferation assessed by CFSE dilution is less sophisticated and widely applicable. The major mugwort allergen, Art v 1, contains only one single, immunodominant, HLA-DR1-restricted epitope (Art v 125-36 ). Thus, essentially all Art v 1-reactive cells should be identified by a HLA-DRB1*01:01/Art v 119-36 tetramer.
METHODS: We compared specificity and sensitivity of tetramer(+) and allergen-induced proliferating (CFSE(lo) ) CD4(+) T cells by flow cytometry.
RESULTS: The frequency of tetramer(+) CD4(+) T cells determined ex vivo in PBMC of mugwort-allergic individuals ranged from 0 to 0.029%. After 2-3 weeks of in vitro expansion, sufficient tetramer(+) T cells for phenotyping were detected in 83% of Art v 125-36 -reactive T-cell lines (TCL) from mugwort-allergic individuals, but not in TCL from healthy individuals. The tetramers defined bona fide Th2 cells. Notably, Art v 125-36 -reactive TCL depleted of tetramer(+) T cells still reacted to the peptide, and only 44% of Art v 125-36 -specific T-cell clones were detected by the tetramer. CFSE(lo) CD4(+) T cells contained only 0.3-10.7% of tetramer(+) T cells and very low proportions of Th2 cells.
CONCLUSION: Allergen-specific T cells can be identified by HLA class II tetramers with high specificity, but unexpected low sensitivity. In contrast, allergen-stimulated CFSE(lo) CD4(+) T cells contain extremely high fractions of bystander cells. Therefore, for T-cell monitoring, either method should be interpreted with caution.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; allergens and epitopes; immunologic tests

Mesh:

Substances:

Year:  2014        PMID: 25236500     DOI: 10.1111/all.12524

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity.

Authors:  Sandeep Kumar Dhanda; Alba Grifoni; John Pham; Kerrie Vaughan; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Immunology       Date:  2017-09-28       Impact factor: 7.397

2.  Predictive in silico binding algorithms reveal HLA specificities and autoallergen peptides associated with atopic dermatitis.

Authors:  Jan J Gong; David J Margolis; Dimitrios S Monos
Journal:  Arch Dermatol Res       Date:  2020-03-09       Impact factor: 3.017

Review 3.  Newly identified T cell subsets in mechanistic studies of food immunotherapy.

Authors:  Vanitha Sampath; Kari C Nadeau
Journal:  J Clin Invest       Date:  2019-04-01       Impact factor: 14.808

Review 4.  Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.

Authors:  S R Prickett; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-06       Impact factor: 5.018

5.  Dramatically decreased T cell responses but persistent IgE upon reduced pollen exposure.

Authors:  Dries Van Hemelen; Wolfgang Hemmer; Maximilian Kmenta; Uwe B Berger; Tamar Kinaciyan; Barbara Bohle; Beatrice Jahn-Schmid
Journal:  Immunobiology       Date:  2019-08-03       Impact factor: 3.144

Review 6.  T Cell Epitope Peptide Therapy for Allergic Diseases.

Authors:  Robyn E O'Hehir; Sara R Prickett; Jennifer M Rolland
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

7.  PD-1 has a unique capacity to inhibit allergen-specific human CD4+ T cell responses.

Authors:  Sandra Rosskopf; Beatrice Jahn-Schmid; Klaus Georg Schmetterer; Gerhard J Zlabinger; Peter Steinberger
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

8.  NSG mice humanized with allergen-specific T-cell lines as in vivo model of respiratory allergy.

Authors:  Caterina Vizzardelli; Felix Zimmann; Birgit Nagl; Claudia Kitzmüller; Ute Vollmann; Miriam Gindl; Simone Tangermann; Beatrice Jahn-Schmid; Lukas Kenner; Barbara Bohle
Journal:  Allergy       Date:  2020-04-03       Impact factor: 13.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.